Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo
Xiaolu Cui, Dezhi Shen, Chuize Kong, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Chemotherapy: a double-edged sword in cancer treatment
Nafiseh Behranvand, Farzad Nasri, Reza Zolfaghari Emameh, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 3, pp. 507-526
Open Access | Times Cited: 220
Transcription Factors in Cancer Development and Therapy
Kanchan Vishnoi, Navin Viswakarma, Ajay Rana, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2296-2296
Open Access | Times Cited: 115
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Stephanie Kourakis, Cara A. Timpani, Judy B. de Haan, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 306-306
Open Access | Times Cited: 74
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas
Marina Salmón, Ruth Álvarez, Coral Fustero‐Torre, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 7
Open Access | Times Cited: 36
Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis
Yazdan Mokhtari, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 639-651
Open Access | Times Cited: 63
STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer
Rômulo S. Cavalcante, Uta Ishikawa, Emanuell S. Silva, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 11, pp. 2284-2304
Open Access | Times Cited: 54
Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells
Elshaddai White, Nakea M. Pennant, Jada R. Carter, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 53
Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette–Guérin Immunotherapy of Bladder Cancer
Omar M. Ibrahim, Paweł Kaliński
Cells (2024) Vol. 13, Iss. 8, pp. 699-699
Open Access | Times Cited: 7
Effects of microRNA-135a on the epithelial–mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway
Xia-Wa Mao, Jiaquan Xiao, Zhongyi Li, et al.
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 1, pp. e429-e429
Open Access | Times Cited: 52
CK2 and the Hallmarks of Cancer
May-Britt Firnau, Angela Brieger
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1987-1987
Open Access | Times Cited: 27
Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review
Connor Chestnut, Dharmalingam Subramaniam, Prasad Dandawate, et al.
Nutrition and Cancer (2020) Vol. 73, Iss. 11-12, pp. 2249-2271
Closed Access | Times Cited: 34
NFκB-Activated COX2/PGE2/EP4 Axis Controls the Magnitude and Selectivity of BCG-Induced Inflammation in Human Bladder Cancer Tissues
Omar M. Ibrahim, Per Basse, Weijian Jiang, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1323-1323
Open Access | Times Cited: 28
RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies
Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Effects of Cheonggukjang (Fermented Soybean) on the Development of Colitis-Associated Colorectal Cancer in Mice
Hyeon-Ji Lim, Insun Park, Su-Ji Jeong, et al.
Foods (2023) Vol. 12, Iss. 2, pp. 383-383
Open Access | Times Cited: 11
Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines
Margaretha A. Skowron, Margarita Melnikova, Joep G.H. van Roermund, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 590-590
Open Access | Times Cited: 38
Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-κB Signaling Pathway in Human Breast Cancer Cells
Xiao-Hu Sun, Xinzhong Chang, Yunhua Wang, et al.
BioMed Research International (2019) Vol. 2019, pp. 1-10
Open Access | Times Cited: 35
Simvastatin Inhibits Endotoxin-Induced Apoptosis in Liver and Spleen Through Up-Regulation of Survivin/NF-κB/p65 Expression
Lana Nežić, Ljiljana Amidžić, Ranko Škrbić, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 34
Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR)
Mir Hadi Jazayeri, Tayebe Aghaie, Reza Nedaeinia, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 9, pp. 1833-1840
Open Access | Times Cited: 30
Helicobacter pylori-induced reactive oxygen species direct turnover of CSN-associated STAMBPL1 and augment apoptotic cell death
Supattra Chaithongyot, Michael Naumann
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 2
Open Access | Times Cited: 18
Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer
Ramin Eskandani, Mohammad Kazempour, Raheleh Farahzadi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113932-113932
Open Access | Times Cited: 18
Oligonol®, an oligomerized polyphenol from Litchi chinensis extract, enhances cisplatin sensitivity and inhibits invasion in bladder cancer cells by the TNF-α/NF-κB/Snail pathway
Chen-Hsin Albert Yu, Hung‐Yu Lin, Sue-Joan Chang, et al.
CyTA - Journal of Food (2025) Vol. 23, Iss. 1
Open Access
NF-κB signaling driven by oncogenic Ras contributes to tumorigenesis in a Drosophila carcinoma model
Caroline Dillard, José Teles-Reis, Ashish Jain, et al.
PLoS Biology (2025) Vol. 23, Iss. 4, pp. e3002663-e3002663
Open Access
Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study
Li Gao, Shenghua Li, Yixin Tian, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 3667-3683
Open Access | Times Cited: 33
The contemporary role and impact of urine-based biomarkers in bladder cancer
Igor Duquesne, Lars Weisbach, Atiqullah Aziz, et al.
Translational Andrology and Urology (2017) Vol. 6, Iss. 6, pp. 1031-1042
Open Access | Times Cited: 31
Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF‐κB‐modulated tumor progression in bladder cancer in vitro and in vivo
Chih‐Hung Chiang, Jing‐Gung Chung, Fei‐Ting Hsu
Environmental Toxicology (2019) Vol. 34, Iss. 6, pp. 679-688
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top